自体骨髓基质细胞蛛网膜下腔移植治疗帕金森叠加综合征
Autologous bone marrow stromal cell transplantation in the treatment of Parkinson's plus syndrome subarachnoid
钟士红1
作者信息
- 1. 南溪区人民医院，四川 宜宾，644100
- 折叠
摘要
目的：探讨帕金森叠加综合征经自体骨髓基质细胞蛛网膜下腔移植临床治疗效果。方法：对照组仅给予常规临床治疗，研究组在常规治疗基础上加用自体骨髓基质细胞蛛网膜下腔移植，记录两组帕金森叠加综合征患者治疗前后生活能力变化情况。结果：两组治疗前生活能力对比结果P>0.05；经不同治疗后两组Barthel指数评分均较之前显著提高，研究组生活能力改善效果优于对照组，数据对比P<0.05。结论：应用自体骨髓基质细胞蛛网膜下腔移植治疗帕金森叠加综合征可获得较为理想的临床疗效，有利于保障患者生活质量。
Abstract
Objective:Parkinson 's plus syndrome after autologous bone marrow stromal cells in clinical treatment of subarachnoid transplantation. Methods:The control group received conventional therapy clinical research group in the conventional treatment based on the use of autologous bone marrow stromal cell transplantation subarachnoid space, before and after recording two Parkinson's plus syndrome patients living changes.Results: Before treatment, the ability to live comparison results P> 0.05; after different treatment groups by prior Barthel index scores were significantly increased, the effect of improving life skills study group than the control group, data comparison P <0.05.Conclusion:Help protect the quality of life of patients.
关键词
帕金森叠加综合征/自体骨髓基质细胞/蛛网膜下腔移植/应用效果Key words
Parkinson's plus syndrome/autologous bone marrow stromal cells/subarachnoid transplantation/application effect引用本文复制引用
出版年
2016
NETL
NSTL
维普
万方数据